FRANCISCO PARTNERS IV, L.P. - 10%+ Owner at GoodRx Holdings, Inc.

Issuer-level insider activity

Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Company
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by FRANCISCO PARTNERS IV, L.P. since 13 Aug 2025

Reported holdings for FRANCISCO PARTNERS IV, L.P. in GoodRx Holdings, Inc.

Form 4 holding 10%+ Owner

GoodRx Holdings, Inc.

Security class
Class B Common Stock
Shares / value
40,019,294
Estimated value
$184,488,945
Report date
16 Mar 2025
Price
$4.61
Ownership
By Francisco Partners IV, L.P.
Underlying class
Class A Common Stock
Underlying amount
Form 4 holding 10%+ Owner

GoodRx Holdings, Inc.

Security class
Class B Common Stock
Shares / value
20,058,890
Estimated value
$92,471,483
Report date
16 Mar 2025
Price
$4.61
Ownership
By Francisco Partners IV-A, L.P.
Underlying class
Class A Common Stock
Underlying amount
Form 4 holding 10%+ Owner

GoodRx Holdings, Inc.

Security class
Class A Common Stock
Shares / value
0
Estimated value
$0
Report date
16 Mar 2025
Price
$4.20
Ownership
By Francisco Partners IV-A, L.P.
Form 4 holding 10%+ Owner

GoodRx Holdings, Inc.

Security class
Class A Common Stock
Shares / value
0
Estimated value
$0
Report date
16 Mar 2025
Price
$4.20
Ownership
By Francisco Partners IV, L.P.

Transaction history for FRANCISCO PARTNERS IV, L.P. in GoodRx Holdings, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .